GCET2 anticorps (AA 31-130) (Biotin)

N° du produit ABIN717733

Détail du produit anti-GCET2 anticorps (Biotin)

Antigène: GCET2 (Germinal Center Expressed Transcript 2 (GCET2))

Épitope: AA 31-130

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GCET2 est conjugé à/à la Biotin

Application: ELISA, Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Souris

Homologie: Human

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human GCET2

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur GCET2

Antigène: GCET2 (Germinal Center Expressed Transcript 2 (GCET2))

Autre désignation: Gcet2 (GCET2 Produits)

Synonymes: anticorps Gcet, anticorps Gcet2, anticorps M17, anticorps M17-L, anticorps GCAT2, anticorps GCET2, anticorps HGAL, anticorps germinal center associated, signaling and motility, anticorps germinal center associated signaling and motility, anticorps germinal center-associated, signaling and motility, anticorps Gcsam, anticorps GCSAM

Sujet:

Synonyms: HGAL, GCAT2, GCET2, Germinal center-associated signaling and motility protein, Germinal center B-cell-expressed transcript 2 protein, Germinal center-associated lymphoma protein, GCSAM, GAL

Background: Involved in the negative regulation of lymphocyte motility. It mediates the migration-inhibitory effects of IL6. Serves as a positive regulator of the RhoA signaling pathway. Enhancement of RhoA activation results in inhibition of lymphocyte and lymphoma cell motility by activation of its downstream effector ROCK. Is a regulator of B-cell receptor signaling, that acts through SYK kinase activation.

ID gène: 257144

UniProt: Q8N6F7